PG 01037 dihydrochloride [675599-62-9]
Cat# T23143-1mg
Size : 1mg
Brand : TargetMol
Contact local distributor :
Phone : +1 850 650 7790
PG 01037 dihydrochloride
(Synonyms: PG-01037 2HCl) Copy Product Info
PG 01037 dihydrochloride (PG-01037 2HCl) is a potent and selective dopamine D3 receptor antagonist with a Ki of 0.7 nM.
Cas No. 675599-62-9
For research use only—not for human use. No sales to individuals. Use as intended only.
Select Batch
Purity:99.89%
Appearance:Solid
Color:White
COA LCMS HNMR
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | PG 01037 dihydrochloride (PG-01037 2HCl) is a potent and selective dopamine D3 receptor antagonist with a Ki of 0.7 nM. |
| Targets & IC50 | D3 receptor:0.7 nM (Ki) |
| Synonyms | PG-01037 2HCl |
| Molecular Weight | 554.34 |
| Formula | C26H28Cl4N4O |
| Cas No. | 675599-62-9 |
| Smiles | ClC1=C(N2CCN(CC2)C/C=C/CNC(C3=CC=C(C4=CC=CC=N4)C=C3)=O)C=CC=C1Cl.Cl.Cl |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 25 mg/mL (45.1 mM), Sonication is recommended.  | |||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 2 mg/mL (3.61 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||